DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Art Pappas will sit on a panel titled "Getting the Funds You Need to Build and Grow Your Company" at the Specialty Pharmaceutical Conference sponsored by the Institute for International Research in Orlando.
News | 04. 11. 2007
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.